- Home
- BLCO vs BCC Comparison
BLCO vs BCC Comparison
Compare BLCO & BCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLCO
- BCC
- Stock Information
- Founded
- BLCO 1853
- BCC 2004
- Country
- BLCO Canada
- BCC United States
- Employees
- BLCO N/A
- BCC N/A
- Industry
- BLCO Ophthalmic Goods
- BCC RETAIL: Building Materials
- Sector
- BLCO Health Care
- BCC Consumer Discretionary
- Exchange
- BLCO Nasdaq
- BCC Nasdaq
- Market Cap
- BLCO 5.6B
- BCC 4.7B
- IPO Year
- BLCO 2022
- BCC 2013
- Fundamental
- Price
- BLCO $14.14
- BCC $98.37
- Analyst Decision
- BLCO Hold
- BCC Buy
- Analyst Count
- BLCO 11
- BCC 7
- Target Price
- BLCO $19.10
- BCC $128.50
- AVG Volume (30 Days)
- BLCO 578.8K
- BCC 447.0K
- Earning Date
- BLCO 04-30-2025
- BCC 05-05-2025
- Dividend Yield
- BLCO N/A
- BCC 5.93%
- EPS Growth
- BLCO N/A
- BCC N/A
- EPS
- BLCO N/A
- BCC 9.57
- Revenue
- BLCO $4,791,000,000.00
- BCC $6,724,294,000.00
- Revenue This Year
- BLCO $6.53
- BCC $1.23
- Revenue Next Year
- BLCO $5.64
- BCC $5.11
- P/E Ratio
- BLCO N/A
- BCC $10.27
- Revenue Growth
- BLCO 15.56
- BCC N/A
- 52 Week Low
- BLCO $13.16
- BCC $95.33
- 52 Week High
- BLCO $21.69
- BCC $155.42
- Technical
- Relative Strength Index (RSI)
- BLCO 26.70
- BCC 36.90
- Support Level
- BLCO $15.23
- BCC $97.44
- Resistance Level
- BLCO $15.77
- BCC $103.44
- Average True Range (ATR)
- BLCO 0.44
- BCC 2.56
- MACD
- BLCO -0.05
- BCC 0.88
- Stochastic Oscillator
- BLCO 11.82
- BCC 37.48
About BLCO Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
About BCC Boise Cascade L.L.C.
Boise Cascade Co is a producer of engineered wood products (EWP) and plywood. The firm operates in two segments namely Wood Products and Building Materials Distribution. Wood Products segment manufactures EWP, consisting of laminated veneer lumber (LVL), I-joists, and laminated beams. The Building Materials Distribution segment is engaged in the wholesale of building materials. It distributes products such as plywood, OSB, and lumber items such as siding, doors, metal products, insulation, and roofing, EWP and others. The company generates a majority of its revenue from the Building Material Distribution segment.